Fig. 5From: Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trialDaily symptom and medication use. A daily symptom score (dSS). B daily medication score (dMS). C daily symptom medication score (dSMS). *P < 0.05Back to article page